Andrew M. Dybalski, RPAC

Andrew Dybalski practices at University Orthopaedic Services - Amherst in Amherst, New York.

Andrew Dybalski's NPI, 1386626117, was assigned on November 17, 2005. Andrew Dybalski holds New York license 009369.

Andrew Dybalski's primary practice is University Orthopaedic Services - Amherst, at 4949 Harlem Rd, Amherst, NY 14226-2500. The practice phone is (716) 204-3200.

Andrew Dybalski's primary practice is University Orthopaedic Services - Amherst in Amherst, New York. The medical group on file is General Physician. Dmand AI also links Andrew Dybalski to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew Dybalski practices. Vendor and product names are available with a free account.

Surgical is Andrew Dybalski's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Andrew Dybalski is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Andrew Dybalski is licensed in New York.

Dmand AI lists arthritis, broken or dislocated ankle/ or foot, bursitis, hand joint or tendon inflammation, joint pain, knee injury, lower back pain and minor injury to a limb among the conditions Andrew Dybalski treats.

CMS data shows 31 Medicare services from Andrew Dybalski across 2 procedure codes in 2024, all of them office visits, for 36 Medicare patients. Medicare paid $1,088 for them. Every service was in an office.

CMS counts 36 Medicare patients who saw Andrew Dybalski in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high cholesterol, and 67% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Andrew Dybalski's median patient age at 65, with 56% women.

In 2024, Andrew Dybalski wrote 107 Medicare Part D claims for 66 patients. 99% of them were for generic drugs. CMS names the drug for 77 of them, across 5 drugs with 11 or more claims each, at $325 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Andrew Dybalski for performance year 2024, reported as part of a group. Andrew Dybalski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Andrew Dybalski from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $173.